In the EU, rare diseases that are also life-threatening or chronically debilitating with a low prevalence and a high level of complexity are defined as orphan diseases.
Biotechnology medicines and therapies use proteins, enzymes, antibodies and other substances natu
Many years can be spent in identifying the therapeutic molecule, determining its genetic sequence
Advanced Therapies refers to the Regulation (EC) No 1394/2007 on advanced therapy medicinal produ
Personalized medicines are about tailoring medical treatments to patients.